{"id":1529,"date":"2016-10-03T12:01:03","date_gmt":"2016-10-03T12:01:03","guid":{"rendered":"http:\/\/entrogen.com\/web4\/?p=1529"},"modified":"2016-10-05T00:22:34","modified_gmt":"2016-10-05T00:22:34","slug":"entrogen-announces-colorectal-cancer-mutation-detection-panel","status":"publish","type":"post","link":"https:\/\/entrogen.com\/web4\/entrogen-announces-colorectal-cancer-mutation-detection-panel\/","title":{"rendered":"EntroGen announces immediate availability of its comprehensive Colorectal Cancer Mutation Detection Panel"},"content":{"rendered":"<p>Los Angeles, California &#8211; October 3, 2016 &#8212; Today EntroGen (<a href=\"http:\/\/www.entrogen.com\">http:\/\/www.entrogen.com<\/a>) announced immediate availability of its new CRC panel targeting mutation status in KRAS, NRAS, BRAF, PIK3CA and AKT1 genes. The panel is validated for several leading real time PCR instruments ubiquitous in laboratories today and produces results in just 90 minutes.<\/p>\n<p>The product comes with data analysis software to automate reporting and includes quality assessment reagents designed to optimize sample input, thus avoiding run failures that are common for DNA from formalin fixed tissue regardless of the detection method.<\/p>\n<p>\u201cIn selecting targets for this panel, we considered the body of scientific evidence, current clinical practice and new targets for which there is a pipeline of drugs in development,\u201d said Dr. Gary Potikyan, Chief Science Officer of EntroGen. \u201cThe panel is highly multiplexed, requiring low amount of input DNA without compromising sensitivity.\u201d<\/p>\n<p>\u201cWe have selected EntroGen\u2019s CRC panel because of its simple workflow, comprehensive coverage, and faster turn-around time, giving us access to actionable mutations in colorectal cancer patients,\u201d said Dr. Sameer S. Talwalkar, MD, Medical Director of Molecular Diagnostics, CPA lab in Louisville, Kentucky. \u201cWe are in the process of validating this panel and are looking forward to launching it in the near future. I expect it to reduce the labor burden in our laboratory and provide our oncologists with the answers they are looking for in a timely and cost-effective manner, even on the most difficult patient samples.\u201d CPA Lab is part of Norton Healthcare.<\/p>\n<p>The Company is obtaining a CE IVD marking in EU. The product is available in the USA for research use.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<br \/>\n<strong>About EntroGen<\/strong> (<a href=\"http:\/\/www.entrogen.com\">http:\/\/www.entrogen.com<\/a>)<\/p>\n<p>Based in Los Angeles, California, EntroGen is a biotechnology company with a focus on molecular diagnostic products in the areas of hematology and oncology. EntroGen has a growing commercial portfolio with many of its products being used to guide and monitor targeted therapies for various malignancies.\u00a0 EntroGen\u2019s footprint reaches every corner of the globe delivering reliable clinical and research products.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>October 3, 2016<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-1529","post","type-post","status-publish","format-standard","hentry","category-news-events"],"_links":{"self":[{"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/posts\/1529","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/comments?post=1529"}],"version-history":[{"count":7,"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/posts\/1529\/revisions"}],"predecessor-version":[{"id":1536,"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/posts\/1529\/revisions\/1536"}],"wp:attachment":[{"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/media?parent=1529"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/categories?post=1529"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/entrogen.com\/web4\/wp-json\/wp\/v2\/tags?post=1529"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}